The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
Due to its immunomodulatory effect, vitamin D has been associated with clinical parameters and outcomes in inflammatory bowel diseases (IBDs) which are chronic conditions of the gastrointestinal tract. Upon synthesis or digestion, vitamin D is metabolized in the liver to form 25(OH)D3, the major cir...
Main Authors: | Anna Zielińska, Aleksandra Sobolewska-Włodarczyk, Maria Wiśniewska-Jarosińska, Anita Gąsiorowska, Jakub Fichna, Maciej Sałaga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/284 |
Similar Items
-
Oxidative Stress Does Not Influence Subjective Pain Sensation in Inflammatory Bowel Disease Patients
by: Anna Krystyna Zielińska, et al.
Published: (2021-08-01) -
The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics
by: Marco Valvano, et al.
Published: (2021-01-01) -
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment
by: Pamela A. Hershberger, et al.
Published: (2013-11-01) -
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)<sub>2</sub>D, but No Difference in Ratio of 25(OH)D/24,25(OH)<sub>2</sub>D and FGF23 Concentrations
by: Mariska C Vlot, et al.
Published: (2019-11-01) -
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
by: Henderson, R, et al.
Published: (1974)